Share this episode:
Artificial intelligence boosts survival rate for stroke victims
Chris Mansi: Founder & CEO, Viz.ai
Every two seconds, someone in the world will have a stroke. Almost two-thirds of survivors leave hospital with some form of disability. It is a battle against time to get the most appropriate medical intervention and treatment for stroke victims and every second counts. Viz.ai, a San Francisco-based applied artificial intelligence company, was established by British neurosurgeon Dr. Chris Mansi with the goal of using A.I. to make healthcare work faster and smarter. He was inspired by a patient who underwent a successful brain operation but died because the surgery came too late. In this LLAMA podcast interview, recorded at TEDMED, Dr. Mansi explains why rapid treatment can mean the difference between life and death – and why he believes medical technology is on the cusp of transforming healthcare and dramatically improving the odds of making a full recovery from a stroke.
Published on: 19 Feb 2019 @ 16:06 PT
NOTES & QUOTES
In this interview we cover:
- The anatomy of a stroke and large vessel occlusions.
- What is mechanical thrombectomy and why is it a “game changer” treatment?
- The devastating impact of strokes and why speed is of the essence in treatment.
- What is Viz.AI
- How does artificial intelligence help save time and save lives.
“Today is a really exciting time in the world of technology and particularly technology applied to healthcare.”
- The correlation between smoking and lifelong risk of a stroke.
- The symptoms to watch out for that could indicate a stroke.
- Will A.I. ever replace doctors?
- How technology is democratizing health care.
“We can now automatically pick up diseases in scans whether it’s an X-ray, a CT or an MRI. We can pick up patterns in genetic data or blood tests or your electronic medical records. And by doing that what it really does is it democratizes care.”
- Why connecting the right doctors at the right time is crucial to save lives.
- How is artificial intelligence acquired?
- How technology standardizes the quality of care.
- Longevity ambitions and daily rules to live by.
“I am very optimistic about the future but what that means is … all the wonderful innovators that I’ve met here (at TEDMED) and beyond really need to focus and work hard to bring this technology to true clinical care. Otherwise it was just a nice toy.”